Trial Profile
Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma: A Phase Ib Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Jan 2024
Price :
$35
*
At a glance
- Drugs Zotiraciclib (Primary) ; Temozolomide
- Indications Anaplastic astrocytoma; Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms STEAM
- 18 Dec 2023 Results assessing dose limiting toxicities of TG02 for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma published in the European Journal of Cancer
- 06 Jun 2023 Results presented at the 59th Annual Meeting of the American Society of Clinical Oncology.
- 27 May 2022 Status changed from active, no longer recruiting to completed.